More Information on 'DiagCor Bioscience Incorporation Limited'

DiagCor Bioscience Incorporation Limited is a dynamic biotechnology company that specializes in the innovation and technology of diagnostic healthcare and research sectors. The company manufactures advanced in-vitro diagnostic products, provides clinical diagnostic services to medical centers in South East Asia, and offers innovative self-collection testing services for health-conscious customers. DiagCor's proprietary 'Flow-through' hybridization technology revolutionizes the concept of conventional DNA array and protein array assays, enabling the development of IVD kits with excellent sensitivity and specificity. The company's products and services include instruments, such as the R2-M flow-through hybridization system and the FT-PRO flow-through hybridization system, as well as kits for HPV array testing, STD array testing, and other diagnostic applications. DiagCor's commitment to innovation, quality, and customer satisfaction has made it a leader in the diagnostic testing industry.

About DiagCor Bioscience Incorporation Limited
DiagCor Bioscience Incorporation Limited (DiagCor) is a dynamic biotechnology company devoted to the innovation and technology in diagnostic healthcare and research sectors. We manufacture advanced in-vitro diagnostic products, provide clinical diagnostic services to medical centers in South East Asia and offer innovative self-collection testing services for health conscious customers to perform testing without visiting the clinics. We invest heavily in research and development which leads to development of our proprietary "Flow-through" hybridization technology. This groundbreaking technology revolutionizes the concept of conventional DNA array and protein array assays. Working on the state-of-the-art "Flow-through" platform, our GenoFlow series of IVD kits offer multi-pathogen / genotype detection with excellent sensitivity and specificity at remarkable efficiency and low cost. We continually innovate our technology and develop IVD kits because we believe that early diagnosis of diseases can greatly improve treatment success, prevent spread of diseases and improve public health.